E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention
Jeffrey Lefkovits,Eric J. Topol +1 more
TL;DR: Although no single drug has conclusively proven effective yet, the promise of a number of agents, together with other nonpharmacological strategies will likely result in further reductions in the incidence of restenosis.
Journal ArticleDOI
Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival
Albert W. Chan,David J. Moliterno,Peter B. Berger,Gregg W. Stone,Peter M. DiBattiste,Steven L Yakubov,Shelly Sapp,Kathy Wolski,Deepak L. Bhatt,Eric J. Topol,Target Investigators +10 more
TL;DR: Among patients undergoing coronary stent placement with aspirin and a GP IIb/IIIa inhibitor, clopidogrel pretreatment is associated with a reduction of death and MI irrespective of the type of GP IIB/ IIIa inhibitor used.
Journal ArticleDOI
One-year follow-up in the coronary angioplasty versus excisional atherectomy trial (CAVEAT I)
John Elliott,Lisa G. Berdan,David R. Holmes,Jeffrey M. Isner,Spencer B. King,Gordon Keeler,Marianne Kearney,Robert M. Califf,Eric J. Topol +8 more
TL;DR: Long-term follow-up of the 1012 patients randomized to atherectomy or angioplasty has revealed a statistically significant excess of deaths after directional atheresctomy that was not evident at 6 months and remains statistically significant at 1 year.
Journal ArticleDOI
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management.
David C. Sane,Robert M. Califf,Eric J. Topol,David C. Stump,Daniel B. Mark,Charles S. Greenberg +5 more
TL;DR: An algorithm is developed for using cryoprecipitate, fresh frozen plasma, and platelets infusion with antifibrinolytic agents as a last alternative for hemorrhage and the role of platelet inhibition should be considered.
Journal ArticleDOI
Diabetes Mellitus, Glycoprotein IIb/IIIa Blockade, and Heparin Evidence for a Complex Interaction in a Multicenter Trial
Neal S. Kleiman,A.M. Lincoff,Dean J. Kereiakes,David P. Miller,Frank V. Aguirre,Keaven M. Anderson,Weisman Hf,Robert M. Califf,Eric J. Topol +8 more
TL;DR: In this paper, the authors analyzed characteristics and outcomes of diabetic patients enrolled in a large multicenter study (EPILOG) and found that after angioplasty, major complications and ischemic events occur more frequently in diabetic than nondiabetic patients.